MC Boffa
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Hematology top 1%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Venous Thromboembolism Diagnosis and Management 7
- Rheumatology 18
- Systemic Lupus Erythematosus Research 18
MC Boffa
28 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Rheumatology 991
- Hematology 655
- Nephrology 264
- Internal Medicine 115
- Hepatology 111
Countries citing papers authored by MC Boffa
This map shows the geographic impact of MC Boffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MC Boffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MC Boffa more than expected).
Fields of papers citing papers by MC Boffa
This network shows the impact of papers produced by MC Boffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MC Boffa. The network helps show where MC Boffa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside MC Boffa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 156 | |
| 2 | 2009 | 9 | |
| 3 | 2009 | 14 | |
| 4 | 2009 | 147 | |
| 5 | 2007 | 60 | |
| 6 | 2004 | 27 | |
| 7 | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines Hit paper breakdown → | 2003 | 547 |
| 8 | 2000 | 4 | |
| 9 | 1998 | 4 | |
| 10 | 1997 | 4 | |
| 11 | 1997 | 14 | |
| 12 | Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. | 1996 | 71 |
| 13 | 1995 | 8 | |
| 14 | 1994 | 43 | |
| 15 | 1993 | 1 | |
| 16 | 1993 | 125 | |
| 17 | Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies. | 1993 | 16 |
| 18 | 1992 | 1 | |
| 19 | 1992 | 31 | |
| 20 | 1992 | 35 |
About MC Boffa
MC Boffa is a scholar working on Internal Medicine, Rheumatology, Hematology, Nephrology and Genetics, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (18 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Diabetes and associated disorders (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Renal Diseases and Glomerulopathies (5 papers), Blood disorders and treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Peripheral Neuropathies and Disorders (2 papers). The work is most often cited by research in Rheumatology (991 citations), Hematology (655 citations), Nephrology (264 citations), Internal Medicine (115 citations) and Hepatology (111 citations). MC Boffa has collaborated with scholars based in France, Italy and Slovenia. Frequent co-authors include Ricard Cervera, J.C. Piette, P G de Groot, Doruk Erkan, Ronald A. Asherson, Yehuda Shoenfeld, Munther A. Khamashta, Eric Lachassinne, M. Bérard and Marina Karmochkine. Their work appears in journals such as Lupus, Blood, Thrombosis Research, The Journal of Urology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.